{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T09:52:54Z","timestamp":1767174774894,"version":"build-2238731810"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T00:00:00Z","timestamp":1675814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T00:00:00Z","timestamp":1675814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007602","name":"Programme Grants for Applied Research","doi-asserted-by":"publisher","award":["PTC-RP-PG-0213-20002"],"award-info":[{"award-number":["PTC-RP-PG-0213-20002"]}],"id":[{"id":"10.13039\/501100007602","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cost Eff Resour Alloc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Emerging evidence suggests that structured and progressive exercise underpinned by a cognitive behavioural approach can improve functional outcomes in patients with neurogenic claudication (NC). However, evidence surrounding its economic benefits is lacking.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To estimate the economic costs, health-related quality of life outcomes and cost-effectiveness of a physical and psychological group intervention (BOOST programme) versus best practice advice (BPA) in older adults with NC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>An economic evaluation was conducted based on data from a pragmatic, multicentre, superiority, randomised controlled trial. The base-case economic evaluation took the form of an intention-to-treat analysis conducted from a UK National Health Service (NHS) and personal social services (PSS) perspective and separately from a societal perspective. Costs (\u00a3 2018\u20132019 prices) were collected prospectively over a 12\u00a0month follow-up period. A bivariate regression of costs and quality-adjusted life-years (QALYs), with multiple imputation of missing data, was conducted to estimate the incremental cost per QALY gained and the incremental net monetary benefit (INMB) of the BOOST programme in comparison to BPA. Sensitivity and pre-specified subgroup analyses explored uncertainty and heterogeneity in cost-effectiveness estimates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Participants (N\u2009=\u2009435) were randomised to the BOOST programme (n\u2009=\u2009292) or BPA (n\u2009=\u2009143). Mean (standard error [SE]) NHS and PSS costs over 12\u00a0months were \u00a31,974 (\u00a3118) in the BOOST arm versus \u00a31,827 (\u00a3169) in the BPA arm (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.474). Mean (SE) QALY estimates were 0.620 (0.009) versus 0.599 (0.006), respectively (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.093). The probability that the BOOST programme is cost-effective ranged between 67 and 83% (NHS and PSS perspective) and 79\u201389% (societal perspective) at cost-effectiveness thresholds between \u00a315,000 and \u00a330,000 per QALY gained. INMBs ranged between \u00a3145 and \u00a3464 at similar cost-effectiveness thresholds. The cost-effectiveness results remained robust to sensitivity analyses.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The BOOST programme resulted in modest QALY gains over the 12\u00a0month follow-up period. Future studies with longer intervention and follow-up periods are needed to address uncertainty around the health-related quality of life impacts and cost-effectiveness of such programmes.<\/jats:p>\n                    <jats:p>\n                      <jats:italic>Trial registration<\/jats:italic>\n                      This study has been registered in the International Standard Randomised Controlled Trial Number registry, reference number ISRCTN12698674. Registered on 10 November 2015.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12962-022-00410-y","type":"journal-article","created":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T04:03:37Z","timestamp":1675829017000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Economic costs, health-related quality of life outcomes and cost-utility of a physical and psychological group intervention targeted at older adults with neurogenic claudication"],"prefix":"10.1186","volume":"21","clinical-trial-number":[{"clinical-trial-number":"isrctn12698674","registry":"10.18810\/isrctn"}],"author":[{"given":"Mandy","family":"Maredza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamran","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioana R.","family":"Marian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan J.","family":"Dutton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah E.","family":"Lamb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stavros","family":"Petrou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,8]]},"reference":[{"key":"410_CR1","doi-asserted-by":"publisher","first-page":"E857","DOI":"10.1097\/BRS.0000000000001635","volume":"41","author":"F Zaina","year":"2016","unstructured":"Zaina F, Tomkins-Lane C, Carragee E, Negrini S. Surgical versus nonsurgical treatment for lumbar spinal stenosis. Spine. 2016;41:E857-e868.","journal-title":"Spine"},{"key":"410_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010712","author":"C Ammendolia","year":"2013","unstructured":"Ammendolia C, Stuber KJ, Rok E, Rampersaud R, Kennedy CA, Pennick V, Steenstra IA, de Bruin LK, Furlan AD. Nonoperative treatment for lumbar spinal stenosis with neurogenic claudication. Cochrane Database Syst Rev. 2013. https:\/\/doi.org\/10.1002\/14651858.CD010712.","journal-title":"Cochrane Database Syst Rev"},{"key":"410_CR3","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1016\/j.apmr.2018.05.014","volume":"99","author":"C Ammendolia","year":"2018","unstructured":"Ammendolia C, C\u00f4t\u00e9 P, Southerst D, Schneider M, Budgell B, Bombardier C, Hawker G, Rampersaud YR. Comprehensive nonsurgical treatment versus self-directed care to improve walking ability in lumbar spinal stenosis: a randomized trial. Arch Phys Med Rehabil. 2018;99:2408-2419.e2402.","journal-title":"Arch Phys Med Rehabil"},{"key":"410_CR4","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1177\/0269215520986688","volume":"35","author":"M Minetama","year":"2021","unstructured":"Minetama M, Kawakami M, Teraguchi M, Kagotani R, Mera Y, Sumiya T, Nakagawa M, Yamamoto Y, Matsuo S, Sakon N, et al. Supervised physical therapy versus unsupervised exercise for patients with lumbar spinal stenosis: 1-year follow-up of a randomized controlled trial. Clin Rehabil. 2021;35:964\u201375.","journal-title":"Clin Rehabil"},{"key":"410_CR5","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s41669-018-0097-9","volume":"3","author":"I Khan","year":"2019","unstructured":"Khan I, Petrou S, Khan K, Mistry D, Lall R, Sheehan B, Lamb S. Does structured exercise improve cognitive impairment in people with mild to moderate dementia? a cost-effectiveness analysis from a confirmatory randomised controlled trial: the dementia and physical activity (DAPA) trial. Pharmaco Economics Open. 2019;3:215\u201327.","journal-title":"Pharmaco Economics Open"},{"key":"410_CR6","doi-asserted-by":"publisher","first-page":"e022205","DOI":"10.1136\/bmjopen-2018-022205","volume":"8","author":"E Williamson","year":"2018","unstructured":"Williamson E, Ward L, Vadher K, Dutton SJ, Parker B, Petrou S, Hutchinson CE, Gagen R, Arden NK, Barker K. Better outcomes for older people with spinal trouble (boost) trial: a randomised controlled trial of a combined physical and psychological intervention for older adults with neurogenic claudication, a protocol. BMJ Open. 2018;8:e022205.","journal-title":"BMJ Open"},{"key":"410_CR7","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.physio.2019.01.019","volume":"105","author":"L Ward","year":"2019","unstructured":"Ward L, Williamson E, Hansen Z, French DP, Boniface G, Rogers D, Lamb SE. Development and delivery of the BOOST (better outcomes for older adults with spinal trouble) intervention for older adults with neurogenic claudication. Physiotherapy. 2019;105:262\u201374.","journal-title":"Physiotherapy"},{"key":"410_CR8","unstructured":"National Institute for Health and Care Excellence (NICE): Guide to the methods of technology appraisal (Chapter 5). National Institute for Health and Care Excellence (NICE) 2013."},{"key":"410_CR9","volume-title":"Unit costs of health and social care 2020","author":"LA Curtis","year":"2020","unstructured":"Curtis LA, Burns A. Unit costs of health and social care 2020. Canterbury: Personal Social Services Research Unit, University of Kent; 2020."},{"key":"410_CR10","volume-title":"NHS supply chain","author":"NHS","year":"2018","unstructured":"NHS. NHS supply chain. London: NHS Digital; 2018."},{"key":"410_CR11","unstructured":"NHS England.: National schedule of NHS costs 2018\/19. 2021."},{"key":"410_CR12","volume-title":"Unit costs of health and social care 2019","author":"LA Curtis","year":"2019","unstructured":"Curtis LA, Burns A. Unit costs of health and social care 2019. Canterbury: University of Kent Personal Social Services Research Unit; 2019."},{"key":"410_CR13","unstructured":"British National Formulary [https:\/\/www.evidence.nhs.uk\/formulary\/bnf\/current]"},{"key":"410_CR14","doi-asserted-by":"crossref","unstructured":"Colombo F, Llena-Nozal A, Mercier J, Tjadens (2011) Help wanted?: providing and paying for long-term care, OECD health policy studies, OECD publishing, Paris. https:\/\/doi.org\/10.1787\/9789264097759-en.","DOI":"10.1787\/9789264097759-en"},{"key":"410_CR15","volume-title":"Employee earnings in the UK 2018","author":"Office for National Statistics","year":"2018","unstructured":"Office for National Statistics. Employee earnings in the UK 2018. London: Office for National Statistics; 2018."},{"key":"410_CR16","unstructured":"EuroQol Research Foundation: EQ-5D-5L user guide. 2019. https:\/\/webarchive.nationalarchives.gov.uk\/ukgwa\/20200501111101mp_\/https:\/\/improvement.nhs.uk\/documents\/6486\/2_-_National_schedule_of_NHS_costs_V2.xlsx. Accessed 7 Feb 2023."},{"key":"410_CR17","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.jval.2012.02.008","volume":"15","author":"B van Hout","year":"2012","unstructured":"van Hout B, Janssen M, Feng Y-S, Kohlmann T, Busschbach J, Golicki D, Lloyd A, Scalone L, Kind P, Pickard ASJVih. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Val Health. 2012;15:708\u201315.","journal-title":"Val Health"},{"key":"410_CR18","unstructured":"Position statement on use of the EQ-5D-5L value set for England (updated October 2019) [https:\/\/www.nice.org.uk\/about\/what-we-do\/our-programmes\/nice-guidance\/technology-appraisal-guidance\/eq-5d-5l]"},{"key":"410_CR19","volume-title":"Statistical analysis with missing data","author":"R Little","year":"1987","unstructured":"Little R, Rubin D. Statistical analysis with missing data. New York: Wiley; 1987."},{"key":"410_CR20","doi-asserted-by":"publisher","first-page":"300","DOI":"10.2307\/2525396","volume":"3","author":"A Zellner","year":"1962","unstructured":"Zellner A, Huang DS. Further properties of efficient estimators for seemingly unrelated regression equations. Int Econ Rev. 1962;3:300\u201313.","journal-title":"Int Econ Rev"},{"key":"410_CR21","volume-title":"Guide to the methods of technology appraisal","author":"NICE","year":"2013","unstructured":"NICE. Guide to the methods of technology appraisal. London: Springer; 2013."},{"key":"410_CR22","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1093\/gerona\/glac063","volume":"77","author":"E Williamson","year":"2022","unstructured":"Williamson E, Boniface G, Marian M, Dutton S, Garrett A, Morris A, Hansen Z, Ward L, Nicolson NJ, Rogers D, Barker KL, Fairbank J, Fitch J, French D, Comer C, Mallen C, Lamb S. The clinical effectiveness of a physiotherapy delivered physical and psychological group intervention for older adults with neurogenic claudication: the BOOST randomised controlled trial. J Gerontol A Biol Sci Med Sci. 2022;77:1654\u201364.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"410_CR23","doi-asserted-by":"publisher","first-page":"e316","DOI":"10.1016\/S2468-2667(22)00004-4","volume":"7","author":"A Stathi","year":"2022","unstructured":"Stathi A, Greaves CJ, Thompson JL, Withall J, Ladlow P, Taylor G, Medina-Lara A, Snowsill T, Gray S, Green C, et al. Effect of a physical activity and behaviour maintenance programme on functional mobility decline in older adults: the REACT (retirement in action) randomised controlled trial. Lancet Public Health. 2022;7:e316\u201326.","journal-title":"Lancet Public Health"},{"key":"410_CR24","doi-asserted-by":"publisher","first-page":"845","DOI":"10.7326\/0003-4819-149-12-200812160-00003","volume":"149","author":"AN Tosteson","year":"2008","unstructured":"Tosteson AN, Lurie JD, Tosteson TD, Skinner JS, Herkowitz H, Albert T, Boden SD, Bridwell K, Longley M, Andersson GB. Surgical treatment of spinal stenosis with and without degenerative spondylolisthesis: cost-effectiveness after 2 years. Ann Intern Med. 2008;149:845\u201353.","journal-title":"Ann Intern Med"},{"key":"410_CR25","doi-asserted-by":"publisher","first-page":"E345","DOI":"10.1097\/BRS.0b013e3181f2ed2f","volume":"36","author":"G Skidmore","year":"2011","unstructured":"Skidmore G, Ackerman SJ, Bergin C, Ross D, Butler J, Suthar M, Rittenberg J. Cost-effectiveness of the X-STOP\u00ae interspinous spacer for lumbar spinal stenosis. Spine. 2011;36:E345\u201356.","journal-title":"Spine"},{"key":"410_CR26","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.jval.2016.05.014","volume":"19","author":"C Schilling","year":"2016","unstructured":"Schilling C, Dowsey MM, Clarke PM, Choong PF. Using patient-reported outcomes for economic evaluation: getting the timing right. Value Health. 2016;19:945\u201350.","journal-title":"Value Health"},{"key":"410_CR27","volume-title":"Review of resource use measures in UK economic evaluations. unit costs of health and social care","author":"CH Ridyard","year":"2015","unstructured":"Ridyard CH, Hughes DA. Review of resource use measures in UK economic evaluations. unit costs of health and social care. Canterbury: Personal Social Services Research Unit. University of Kent; 2015."}],"updated-by":[{"DOI":"10.1186\/s12962-023-00431-1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T00:00:00Z","timestamp":1681171200000}}],"container-title":["Cost Effectiveness and Resource Allocation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12962-022-00410-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12962-022-00410-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12962-022-00410-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T02:04:19Z","timestamp":1681265059000},"score":1,"resource":{"primary":{"URL":"https:\/\/resource-allocation.biomedcentral.com\/articles\/10.1186\/s12962-022-00410-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,8]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["410"],"URL":"https:\/\/doi.org\/10.1186\/s12962-022-00410-y","relation":{},"ISSN":["1478-7547"],"issn-type":[{"value":"1478-7547","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,8]]},"assertion":[{"value":"6 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been corrected since original publication; please see the linked erratum for further details.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2023","order":7,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":8,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12962-023-00431-1","URL":"https:\/\/doi.org\/10.1186\/s12962-023-00431-1","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval for the BOOST trial was given by the London-Brent National Research Ethics Committee (REC number 16\/LO\/0349) on March 3, 2016. All participants provided written informed consent prior to enrolment in the trial.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14"}}